Christian Homsy


Christian Homsy, MD, MBA has been the Chief Executive Officer (CEO) of Cardio3BioSciences since its inception. Cardio3 BioSciences is Belgian leading biopharmaceutical company focused on the discovery, development and commercialization of innovative regenerative, protective and reconstructive therapies for the treatment of cardiac diseases.
Drawing on his medical and business experience in senior research and development, marketing, sales and business development, he aims with his team at bringing to physicians and patients worldwide, the first effective regenerative medicine for the treatment of cardiac diseases.